Live Breaking News & Updates on Fatty Acid Oil

Stay updated with breaking news from Fatty acid oil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lexaria Bioscience : Corporate Highlight Sheet -November 02, 2023 at 01:09 pm EDT

LEXARIA BIOSCIENCE CORP.

NASDAQ: LEXX

INVESTOR CONTACT

Phone: 250-765-6424 ext. 202. ....

British Columbia , John Docherty , Chris Bunka , Lexaria Corp , Lexaria Nutraceutical Corp , Securities Exchange , Lexaria Nicotine , Altria Corp , Health Canada , Lexaria Bioscience Corp , Lexaria Hemp Corp , Lexaria Pharmaceutical Corp , Fatty Acid Oil , Helix Biopharma Corp , Lexaria Peer Reviewed Published Research , Drug Administration , Study Program , Altria Group , Bioscience Corp , Active Pharmaceutical Ingredients , Investigational New Drug , Mccurdy Road , Hypoxic Pulmonary Vasoconstriction , Swedish Match , Clinical Study , Peer Reviewed Published Research ,

Lexaria Bioscience : Corporate Highlight Sheet -October 24, 2023 at 05:49 pm EDT

LEXARIA BIOSCIENCE CORP.

NASDAQ: LEXX

INVESTOR CONTACT

Phone: 250-765-6424 ext. 202. ....

British Columbia , John Docherty , Chris Bunka , Altria Group , Lexaria Nutraceutical Corp , Fatty Acid Oil , Health Canada , Lexaria Peer Reviewed Published Research , Drug Administration , Study Program , Helix Biopharma Corp , Lexaria Hemp Corp , Lexaria Pharmaceutical Corp , Lexaria Nicotine , Securities Exchange , Lexaria Corp , Altria Corp , Lexaria Bioscience Corp , Bioscience Corp , Active Pharmaceutical Ingredients , Investigational New Drug , Mccurdy Road , Hypoxic Pulmonary Vasoconstriction , Swedish Match , Clinical Study , Peer Reviewed Published Research ,

Lexaria Bioscience : Corporate Highlight Sheet -Today at 06:47 pm

LEXARIA BIOSCIENCE CORP.

NASDAQ: LEXX

INVESTOR CONTACT

Phone: 250-765-6424 ext. 202. ....

British Columbia , John Docherty , Chris Bunka , Lexaria Nicotine , Altria Corp , Lexaria Corp , Drug Administration , Lexaria Peer Reviewed Published Research , Lexaria Hemp Corp , Helix Biopharma Corp , Lexaria Bioscience Corp , Study Program , Securities Exchange , Lexaria Pharmaceutical Corp , Fatty Acid Oil , Altria Group , Bioscience Corp , Active Pharmaceutical Ingredients , Investigational New Drug , Mccurdy Road , Hypoxic Pulmonary Vasoconstriction , Swedish Match , Clinical Study , Peer Reviewed Published Research , Helix Biopharma , Securities Act ,

Lexaria Bioscience : Corporate Highlight Sheet

LEXARIA BIOSCIENCE CORP.

NASDAQ: LEXX

INVESTOR CONTACT

Phone: 250-765-6424 ext. 202. ....

British Columbia , United States , Chris Bunka , John Docherty , Drug Administration , Lexaria Nicotine , British American Tobacco , Altria Corp , Helix Biopharma Corp , Securities Exchange , Lexaria Corp , Altria Group , Study Program , Lexaria Hemp Corp , Lexaria Bioscience Corp , Fatty Acid Oil , Lexaria Pharmaceutical Corp , Company Plans To Seek Approvals , Bioscience Corp , Active Pharmaceutical Ingredients , New Drug , Mccurdy Road , Hypoxic Pulmonary Vasoconstriction , Pulmonary Hypertension Clinical Study , Data From This Human Study , Together With ,

Lexaria Bioscience : Corporate Highlight Sheet

LEXARIA BIOSCIENCE CORP.

NASDAQ: LEXX

INVESTOR CONTACT

Phone: 250-765-6424 ext. 202. | May 1, 2023 ....

British Columbia , United States , John Docherty , Chris Bunka , Helix Biopharma Corp , Altria Corp , Securities Exchange , Drug Administration , Lexaria Pharmaceutical Corp , Lexaria Nicotine , Altria Group , Fatty Acid Oil , Lexaria Bioscience Corp , British American Tobacco , Lexaria Corp , Lexaria Hemp Corp , Bioscience Corp , Active Pharmaceutical Ingredients , New Drug , Mccurdy Road , British American , North American , Helix Biopharma , Securities Act , Securities Exchange Act , Lexaria Bioscience ,